Abstract
The screening and detection of recurrent medulloblastoma presents the clinician with significant diagnostic challenges, including the risk of misdiagnosis. The authors present the case of a young girl with a history of a treated standard-risk medulloblastoma that highlights the risk of assuming recurrence has occurred when clinical and/or imaging changes are observed. This girl developed both new clinical deficits and had radiographic evidence of recurrence. She subsequently experienced a complete resolution of symptoms and radiographic findings with steroids alone.
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Cerebellar Neoplasms / complications
-
Cerebellar Neoplasms / diagnosis*
-
Cerebellar Neoplasms / diagnostic imaging
-
Cerebellar Neoplasms / drug therapy
-
Cerebellar Neoplasms / pathology
-
Child
-
Dexamethasone / therapeutic use*
-
Diagnosis, Differential
-
Diagnostic Errors*
-
Fatigue / etiology
-
Female
-
Headache / etiology
-
Humans
-
Magnetic Resonance Imaging
-
Medulloblastoma / complications
-
Medulloblastoma / diagnosis*
-
Medulloblastoma / diagnostic imaging
-
Medulloblastoma / drug therapy
-
Medulloblastoma / pathology
-
Neoplasm Recurrence, Local / complications
-
Neoplasm Recurrence, Local / diagnosis*
-
Neoplasm Recurrence, Local / diagnostic imaging
-
Neoplasm Recurrence, Local / drug therapy
-
Palliative Care / methods
-
Tomography, X-Ray Computed
-
Treatment Outcome
-
Treatment Refusal
-
Vision Disorders / etiology
-
Vomiting / etiology
Substances
-
Antineoplastic Agents
-
Dexamethasone